Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions Class A Ordinary Shares

MNDR · NASDAQ · Healthcare / Health Information Services

0.9452USD+0.01 (+1.46%)

Price History

Full chart

Market Stats

Previous Close0.9316
Open0.96
Day Range0.9308 – 0.9731
52-Week Range0.4004 – 5.42
Volume110.24K
Market Cap1.55M
P/E (TTM)0.00
Forward P/E0.00
EPS-13.72
Dividend Yield0.00%
Beta-0.81
50-Day Avg1.69
200-Day Avg4.47

About

Mobile-health Network Solutions, an investment holding company, provides telehealth solutions primarily in Singapore. The company operates in two segments: Telemedicine and Other Services and Sale of Medicine and Medical Devices. It offers MaNaDr platform, a 360-degree healthcare ecosystem, which connects users and service providers through the range of healthcare services and product offerings that can be accessed through the mobile application and website, as well as Internet search engines. The company also provides a suite of medical-related and other services, including teleconsultations and health check-up services, vaccinations, skin and aesthetics services, and other services. In addition, it offers healthcare and wellness products through its online e-commerce platform; wholesale distribution of pharmaceutical products to clinics through MaNaPharma platform; and MaNaCare, a platform that provides a range of corporate healthcare and wellness services, including GP, specialist and allied healthcare panel services, tele-consultation services, in-person clinics, on-site health screening, and online marketplace, as well as wellness programs to corporate customers. Further, the company develops IT systems on mobile phone and web portals; operates pharmacies, clinics, and drug stores; and offers beauty and other personal care services, as well as other general medical services. Additionally, it offers health supplements, skincare, nutrition products and medical devices wellness, personal care; health screening packages; and online services such as medical screenings and procedures, such as serology and swab tests. The company was founded in 2009 and is headquartered in Singapore.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEODr. Tung Yeng Siaw
  • Employees73
  • HeadquartersNo. 07-06/07 Vision Exchange, Singapore, Singapore, 608526, USA
  • Websitehttps://manadr.com

Leadership

  • Dr. Tung Yeng SiawCo-Founder, Co-CEO & Chairman of the Board · b. 1966
  • Dr. Pui Pui TeohCo-Founder, Co-CEO, COO & Director · b. 1978
  • Mr. Aik Huat LeongChief Financial Officer · b. 1967
  • Ms. Siew Siew ChanChief Technology Officer · b. 1985
  • Dr. Seng Taat SiawChief Medical Officer · b. 1995
  • Mr. Chien Howh ChinFinancial Controller · b. 1989

Financials

Income Statement

Currency: USD2021-06-302022-06-302023-06-302024-06-302025-06-30
Total Revenue1.92M6.99M7.87M13.97M5.77M
Growth (%)-+264.35%+12.68%+77.38%-58.68%
Cost of Revenue2.12M5.05M6.79M11.43M6.43M
Gross Profit-200.45K1.94M1.09M2.54M-660.98K
Gross Margin-10.45%27.69%13.90%18.17%-11.45%
Operating Expense274.41K1.79M3.50M18.09M2.01M
Operating Income-474.86K142.41K-2.41M-15.55M-2.68M
Operating Margin-24.76%2.04%-30.60%-111.36%-46.36%
EBITDA-429.19K280.76K-3.19M-15.55M-2.42M
EBITDA Margin-22.37%4.02%-40.56%-111.36%-42.00%
Net Income-460.15K92.70K-2.35M-15.60M-2.55M
Net Income Margin-23.99%1.33%-29.90%-111.70%-44.25%
Interest Expense140---
Interest Expense % of Total Revenue0.00%0.00%---

Balance Sheet

Currency: USD2021-06-302022-06-302023-06-302024-06-302025-06-30
Total Assets693.92K7.73M3.44M7.95M3.49M
Total Liabilities5.18M2.32M3.81M3.81M1.44M
Total Equity-4.48M8.44M-367.20K4.14M2.05M
Cash121.39K7.36M2.23M6.71M811.92K
Total Debt81.72K59.12K422.70K411.38K243.87K
Net Debt-39.68K-7.30M-1.80M-6.30M-568.05K

Cash Flow

Currency: USD2021-06-302022-06-302023-06-302024-06-302025-06-30
Operating Cash Flow-475.05K975.66K-2.25M-6.41M-3.29M
Investing Cash Flow-3.78K-15.21K-186.00K-134.21K-1.84M
Financing Cash Flow387.59K9.23M-5.80M10.88M723.85K
Capital Expenditure3.78K11.19K136.29K134.21K47.66K
Free Cash Flow-478.84K706.25K-1.78M-6.54M-3.34M
FCF to OCF100.80%72.39%79.34%102.10%101.45%

Earnings

Report DateOct 23, 2024Jun 16, 2025Oct 31, 2025Oct 30, 2026
EPS Estimate0.000.000.00-
EPS Actual-3.84-1.92-1.90-
Surprise----
Timing----

Key Statistics & Ratios

Market Cap1.55M
Enterprise Value-1.69M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.21
Price / Book0.20
EPS-13.72
Book Value14.36
Revenue (TTM)7.32M
Gross Profit (TTM)1.44M
EBITDA-2.50M
Profit Margin-35.33%
Operating Margin-22.22%
Return on Equity-47.59%
Return on Assets-23.55%
Shares Outstanding888.59K
Shares Float398.28K
Beta-0.81
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 1 analystsTarget 8.00
  • Strong Buy
    1

Ownership Breakdown

Institutions
3.97%
Insiders
44.16%
Retail / Other
51.87%

Top Institutional Holders

  • Citadel Advisors Llc
    10.61K0.89%
  • Virtu Financial LLC
    26.30K0.37%
  • UBS Group AG
    7.91K0.11%
  • SBI Securities Co Ltd
    410.00%
  • Jane Street Group LLC
    00.00%
  • HRT FINANCIAL LLC
    00.00%

Stock Splits

  • Jun 29, 20261:6
  • Sep 25, 20251:5
  • Mar 10, 20251:8